Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs

Nicolas Duhem , Julien Rolland (1) , Raphaël Riva (2) , Pierre Guillet (3) , Jean-Marc Schumers , Christine Jérôme (4) , Jean-François Gohy (5) , Véronique Préat (6)

1 IMCN - Institut de la matière condensée et des nanosciences / Institute of Condensed Matter and Nanosciences
2 AMPERE - Ampère
3 LCBOSMV - Laboratoire de Chimie Bioorganique et des Systèmes Moléculaires Vectoriels
4 Center for Education and Research on Macromolecules
5 UCL - Université Catholique de Louvain = Catholic University of Louvain
6 Advanced Drug Delivery and Biomaterials [Brussels, Belgium]

Domains: Chemical Sciences; Chemical Sciences; Polymers; Life Sciences [q-bio]; Biotechnology; Life Sciences [q-bio]; Pharmaceutical sciences; Life Sciences [q-bio]; Pharmaceutical sciences; Medication

Nicolas Duhem, Julien Rolland, Raphaël Riva, Pierre Guillet, Jean-Marc Schumers, et al.. Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs. International Journal of Pharmaceutics, 2012, 423 (2), pp.452 - 460. ⟨10.1016/j.ijpharm.2011.12.010⟩. ⟨hal-01645569⟩